Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-10-27 | 2023-12-01 | 208388 |
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209954 |
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2024-02-23 | 2024-03-29 | 220456 |
APO-MONTELUKAST | 10MG | TABLET | Resolved | 2024-03-22 | 2024-04-19 | 223058 |
APO-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2017-03-10 | 2017-04-27 | 399 |
APO-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2017-11-07 | 2018-03-27 | 28556 |
APO-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2018-01-18 | 2018-03-13 | 36435 |
APO-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2018-04-10 | 2019-07-17 | 45365 |
APO-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2018-05-02 | 2018-07-12 | 47966 |
APO-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2019-10-30 | 2020-03-09 | 97474 |
APO-MOXIFLOXACIN | 400MG | TABLET TABLET | Resolved | 2022-06-06 | 2022-09-06 | 162094 |
APO-MOXIFLOXACIN | 400MG | TABLET TABLET | Resolved | 2023-08-18 | 2023-12-01 | 202397 |
APO-MOXIFLOXACIN | 400MG | TABLET TABLET | Actual shortage | 2024-05-03 | 2024-05-03 | 227025 |
APO-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2017-05-04 | 2017-07-04 | 8877 |
APO-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2017-09-05 | 2017-10-16 | 20927 |
APO-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2018-05-08 | 2018-09-11 | 48841 |
APO-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2018-10-11 | 2019-06-08 | 63796 |
APO-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2019-04-04 | 2019-11-05 | 80542 |
APO-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2019-12-05 | 2020-06-22 | 100301 |
APO-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2020-02-13 | 2020-10-13 | 106000 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |